Citations

Showing 10 of 108083 citations.

When Is “Never Enough” (Data) … Enough?
Wedel, Denise J., Kopp, Sandra L. , Johnson, Rebecca L. , Kopp, Sandra

Mayo Clinic

Anesthesia & Analgesia | November 19, 2017 | Volume: 125 | Issue: 6 | Pages: 1833-1834

10.1213/ane.0000000000002202 | PMID 29189359 Get It

Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease
Graham, Brendan C. , Pulido, José S. , Winters, Jeffrey L. , Winters, Jeffrey L

Mayo Clinic

Journal of Clinical Apheresis | November 18, 2017 | Volume: 33 | Issue: 3 | Pages: 380-392

10.1002/jca.21607 | PMID 29150864 Get It

AbstractApheresis procedures have a role in treatment of disparate diseases involving many different organ systems. Often the disease processes where apheresis plays a role in treatment are considered “orphan diseases”—relatively rare disease processes that lack specific pharmaceutical agents or established treatment protocols. Many of these disease processes can affect the eye with devastating results for the eyesight of these patients. The unique ability of apheresis to affect disease by modifying blood plasma and modulating disease‐causing agents therein renders apheresis procedures valuable tools in the treatment of certain ophthalmologic diseases. This review comprehensively evaluates the role of apheresis in the treatment of ophthalmologic diseases of the eye and surrounding orbit including age‐related macular degeneration, bilateral diffuse uveal melanocytic proliferation, paraneoplastic retinopathy, atopic keratoconjunctivitis, sympathetic ophthalmia, and endocrine‐associated ophthalmopathy. Apheresis procedure parameters are provided for the apheresis practitioner based on review of the relevant literature.
Development of an in vivo mouse model of discogenic low back pain
Shi, Changgui , Das, Vaskar, Li, Xin , Kc, Ranjan , Qiu, Sujun , O‐Sullivan, InSug , Ripper, Richard, Kroin, Jeffrey S., Mwale, Fackson , Wallace, Atiyayein A., Zhu, Bingqian , Wijnen, André J. van , Ji, Ming-liang , Lü, Jun , Votta‐Velis, Gina , Yuan, Wen, Im, Hee‐Jeong , van Wijnen, Andre J , Zhao, Lan , Yuan, Wen

Mayo Clinic

Journal of Cellular Physiology | November 18, 2017 | Volume: 233 | Issue: 10 | Pages: 6589-6602

10.1002/jcp.26280 | PMID 29150945 Get It

Discogenic low back pain (DLBP) is extremely common and costly. Effective treatments are lacking due to DLBP's unknown pathogenesis. Currently, there are no in vivo mouse models of DLBP, which restricts research in this field. The aim of this study was to establish a reliable DLBP model in mouse that captures the pathological changes in the disc and allows longitudinal pain testing. The model was generated by puncturing the mouse lumbar discs (L4/5, L5/6, and L6/S1) and removing the nucleus pulposus using a microscalpel under the microscope. Histology, molecular pathways, and pain‐related behaviors were examined. Over 12 weeks post‐surgery, animals displayed the mechanical, heat, and cold hyperalgesia along with decreased burrowing and rearing. Histology showed progressive disc degeneration with loss of disc height, nucleus pulposus reduction, proteoglycan depletion, and annular fibrotic disorganization. Immunohistochemistry revealed a substantial increase in inflammatory mediators at 2 and 4 weeks. Nerve growth factor was upregulated from 2 weeks to the end of the experiment. Nerve fiber ingrowth was induced in the injured discs after 4 weeks. Disc‐puncture also produced an upregulation of neuropeptides in dorsal root ganglia neurons and an activation of glial cells in the spinal cord dorsal horn. These findings indicate that the cellular and structural changes in discs, as well as peripheral and central nervous system plasticity, paralleled persistent, and robust behavioral pain responses. Therefore, this mouse DLBP model could be used to investigate mechanisms underlying discogenic pain, thereby facilitating effective drug screening and development of treatments for DLBP.
Navigating the Clinical Translation of Medical Devices: The Case of Radiofrequency Ablation
Flores, Abdel Armaiz, Velez, Marianna L. Oppenheimer, Thompson, Scott M. , Windebank, Anthony J. , Greenberg, Alexandra J. , Armaiz Flores, Abdel, Oppenheimer Velez, Marianna L, Greenberg-Worisek, Alexandra J

Mayo Clinic

Clinical and Translational Science | November 18, 2017 | Volume: 11 | Issue: 1 | Pages: 8-10

10.1111/cts.12516 | PMID 29150914 Get It

Use of an Articulating Hinge to Facilitate Cervicothoracic Deformity Correction During Vertebral Column Resection
Iyer, Rajiv R. , Elder, Benjamin D. , Sacks, Justin M., Suk, Ian, Wolinsky, Jean‐Paul , Garzón-Muvdi, Tomás

Mayo Clinic

Operative Neurosurgery | November 18, 2017 | Volume: 15 | Issue: 3 | Pages: 278-284

10.1093/ons/opx221 | PMID 29165712 Get It

Abstract BACKGROUND Surgical treatment of severe cervicothoracic kyphotic deformity may require the use of 3-column osteotomies such as the pedicle subtraction osteotomy and vertebral column resection (VCR), or VCR with anterior longitudinal ligament resection. Such procedures are extensive and are associated with high intra- and perioperative morbidity, in part, due to the need for risky reduction maneuvers. OBJECTIVE To describe a novel technique utilizing a laterally placed articulating hinge to facilitate kyphotic deformity correction of the cervicothoracic spine. METHODS A patient with severe chin-on-chest deformity of the cervicothoracic spine presented for evaluation and a 2-stage VCR with anterior longitudinal ligament resection was planned. To reduce the risk of intraoperative neurological injury and for increased control during reduction maneuvers, lateral instrumentation was placed through the chest wall resection above and below the level of VCR, which was adjoined with an articulating hinge rod apparatus. RESULTS Satisfactory reduction of the kyphosis was achieved utilizing the hinge rod apparatus for controlled deformity correction. The patient remained neurologically intact following this procedure with improvement in their spinal alignment. CONCLUSION We present a novel technique utilizing a lateral hinge rod apparatus for efficient, controlled correction of severe kyphotic deformity.
How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy?
St-Germain, Amélie Tremblay, Abdolell, Mohamed , Smoot, Rory L. , Jhaveri, Kartik , Smoot, Rory L , Costa, Andreu F. , Cleary, Sean P.

Mayo Clinic

Journal of Computer Assisted Tomography | November 17, 2017 | Volume: 42 | Issue: 3 | Pages: 380-386

10.1097/rct.0000000000000691 | PMID 29189403 Get It

Objective The objective of this study was to assess the accuracy of gadoxetic acid hepatic enhancement indices in predicting posthepatectomy liver failure (PHLF) and other major complications (OMCs). Methods Sixty-five patients underwent prehepatectomy gadoxetic acid–enhanced magnetic resonance imaging. Enhancement indices were calculated by obtaining regions of interest on magnetic resonance images and segmented volumes of the liver and spleen. Multivariate regression analysis was performed to predict PHLF and OMC as a function of the indices, and areas under the receiver operator characteristic (AUROC) curves were calculated. Results Areas under the receiver operator characteristic values varied from 0.412 to 0.681 and 0.462 to 0.738 in predicting PHLF and OMC, respectively. The most accurate indices in predicting PHLF were the region of interest–based, fat-normalized relative liver enhancement and liver enhancement index (AUROC, 0.681). The most accurate index in predicting OMC was the volumetric least-squares regression slope of a pharmacokinetic model (K hep_V, AUROC, 0.738). Conclusions Indices of gadoxetic acid liver enhancement demonstrate variable performance in predicting PHLF and OMC.
Computed Tomography-Based Texture Analysis to Determine Human Papillomavirus Status of Oropharyngeal Squamous Cell Carcinoma
Ranjbar, Sara , Ning, Shuluo , Zwart, Christine M. , Wood, Christopher P. , Weindling, Steven M. , Mitchell, J. Ross , Li, Jing , Wu, Teresa , Hoxworth, Joseph M.

Mayo Clinic

Journal of Computer Assisted Tomography | November 17, 2017 | Volume: 42 | Issue: 2 | Pages: 299-305

10.1097/rct.0000000000000682 | PMID 29189396 Get It

ObjectiveTo determine whether machine learning can accurately classify human papillomavirus (HPV) status of oropharyngeal squamous cell carcinoma (OPSCC) using computed tomography (CT)-based texture analysis.MethodsTexture analyses were retrospectively applied to regions of interest from OPSCC primary tumors on contrast-enhanced neck CT, and machine learning was used to create a model that classified HPV status with the highest accuracy. Results were compared against the blinded review of 2 neuroradiologists.ResultsThe HPV-positive (n = 92) and -negative (n = 15) cohorts were well matched clinically. Neuroradiologist classification accuracies for HPV status (44.9%, 55.1%) were not significantly different (P= 0.13), and there was a lack of agreement between the 2 neuroradiologists (κ = −0.145). The best machine learning model had an accuracy of 75.7%, which was greater than either neuroradiologist (P< 0.001,P= 0.002).ConclusionsUseful diagnostic information regarding HPV infection can be extracted from the CT appearance of OPSCC beyond what is apparent to the trained human eye.
Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation
Rastogi, Neha , Abraham, Roshini S. , Chadha, Ritu , Thakkar, Dhwanee, Kohli, Shruti, Nivargi, Sagar , Yadav, Satya Prakash

Mayo Clinic

Journal of Pediatric Hematology/Oncology | November 17, 2017 | Volume: 40 | Issue: 6 | Pages: e383-e388

10.1097/mph.0000000000000995 | PMID 29189513 Get It

Emberger syndrome with underlying guanine-adenine-thymine-adenine 2 (GATA2) mutation is a rare disorder and very few successful nonmyeloablative allogeneic hematopoietic stem cell transplants (HSCTs) have been reported. We report a case of Emberger syndrome with GATA2 mutation in a 9-year-old girl who presented with congenital sensorineural deafness, warts, lymphedema, and Myelodysplastic syndrome. Her sister had died of a similar illness. She underwent a nonmyeloablative matched related donor peripheral blood HSCT with rabbit antithymoglobulin (5 mg/kg), fludarabine (160 mg/m2), cyclophophamide (29 mg/kg), and total body irradiation (2 Gray). Graft versus host disease prophylaxis consisted of tacrolimus and mycophenolate moefetil. She had neutrophil engraftment on day+15 and fully donor chimerism by day+30. She developed limited chronic skin graft versus host disease on tapering off immunosuppression. She is disease free on day+475. The review of literature showed a total of 28 patients with GATA2 mutation have undergone HSCT mostly nonmyeloablative and overall survival is 75%. Nonmyeloablatove HSCT is feasible and safe for the patients with GATA2 mutation.
Methamphetamine Use With Subsequent Thyrotoxicosis/Thyroid Storm, Agranulocytosis, and Modified Total Thyroidectomy: A Case Report
Menapace, Deanna C., Headley, Don B., Viswanath, Omar

Mayo Clinic

Clinical Medicine Insights: Ear, Nose and Throat | November 17, 2017 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/1179550617741293 | PMID 29200896 Get It

Thyroid storm is a rare, potentially lethal condition involving collapse of the hypothalamic-pituitary-thyroid feedback loop. Thyroid storm carries a significant mortality rate, thus requiring prompt identification and treatment. A 47-year-old woman presented to the emergency department complaining of palpitations, shortness of breath, and emesis for 24 hours after using methamphetamine. Past medical history was significant for untreated hyperthyroidism. Physical examination revealed a prominent, palpable thyroid. The Burch-Wartofsky-Score was 35. Management for thyroid storm included propylthiouracil (PTU), super saturated potassium iodide, intravenous hydrocortisone, and propranolol. However, a rare drug reaction to PTU on day 3 resulted in agranulocytosis. Propylthiouracil was withheld and a modified total thyroidectomy performed on day 8 without complications and the patient discharged on day 10 with levothyroxine. Undertreated hyperthyroidism may predispose patients to catecholamine-induced thyrotoxicosis due to catecholamine hypersensitivity. With known methamphetamine use, methamphetamine toxicity and a methamphetamine-exacerbated thyroid storm need to be included in the differential diagnosis in a patient presenting with signs of thyrotoxicosis. In addition, treating patients with agranulocytosis from PTU with a modified total thyroidectomy using ligation of the vascular supply as the initial surgical step limits release of thyroid hormone into the blood stream during thyroidectomy and decreases the possibility of intra operative thyroid storm.
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Catalano, John, Belch, Andrew , Cavo, Michèle , Pinto, Antonello, Banos, Anne , Tiab, Mourad, Delforge, Michel , Cavenagh, Jamie, Lee, Je‐Jung , Chen, Christine , Oriol, Albert , Rubia, Javier de la , White, Darrell , Binder, Daniel, Moreau, Philippe , Perrot, Aurore , Arnulf, Bertrand , Qiu, Lugui , Roussel, Murielle , Boyle, Eileen M. , Manier, Salomon , Mohty, Mohamad , Avet‐Loiseau, Hervé , Leleu, Xavier , Ervin‐Haynes, Annette, Chen, Guang , Houck, Vanessa, Benboubker, Lotfi , Hulin, Cyrille , Pinto, Antonio , Moreau, Philippe , Perrot, Aurore , Boyle, Eileen M , Facon, Thierry T.F. , Dimopoulos, Meletios Α. , Dispenzieri, Angela , Pinto, Antonello, Weisel, Katja C , Ludwig, Heinz , Bahlis, Nizar Jacques , Geraldes, Catarina , Lu, Jin Ping , Anderson, Kenneth C. , Attal, Michel , Qiu, Lugui , Roussel, Murielle , Pinto, Antonio , Oriol, Albert , Mohty, Mohamad

Mayo Clinic

Blood | November 17, 2017 | Volume: 131 | Issue: 3 | Pages: 301-310

10.1182/blood-2017-07-795047 | PMID 29150421 Get It

Key Points Rd continuous significantly extended OS compared with MPT and resulted in comparable OS to that with Rd18 in patients with multiple myeloma. Patients achieving complete or very good partial response with Rd benefited greatly from continuous vs fixed treatment in terms of PFS.